Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ACTB
REST API REST API
Homo sapiens
ACTB is differentially expressed in 307 experiments: 147 organism parts: liver, pancreas, ... (145 more);, 245 disease states: normal, glioblastoma, ... (243 more);, 101 cell types 368 cell lines 38 compound treatments and 89 other conditions.
Orthologs Actb (Rattus norvegicus)   Actb (Mus musculus)   ACT1 (Saccharomyces cerevisiae)   Q9TTW4_BOVIN (Bos taurus)   F6QBJ1_CIOIN (Ciona intestinalis)   actb (Xenopus laevis)   ACTB_CANFA (Canis familiaris)   (Compare orthologs)
InterPro Term Actin-like
Gene Ontology Term cytosol, adherens junction organization, protein binding, cytoskeleton, axon, cytoplasm, cellular component movement, protein complex, ribonucleoprotein complex, NuA4 histone acetyltransferase complex, cell-cell junction organization, protein folding, cellular protein metabolic process, blood coagulation, myofibril, soluble fraction, kinesin binding, ATP binding, axon guidance, sarcomere organization, actin cytoskeleton, protein kinase binding, cortical cytoskeleton, nucleotide binding, axonogenesis, structural constituent of cytoskeleton, filamentous actin, 'de novo' posttranslational protein folding, Tat protein binding, response to calcium ion, MLL5-L complex, nitric-oxide synthase binding, cell junction assembly
UniProt Accession A5GZ75, Q96FU6, Q96DE1, Q562Z7, Q9UE89, A1E282, Q6PJ43, Q1KLZ0, A4UCT3, P60709, B3KWQ3, C9JTX5, B4E335, C9JUM1, C9JZR7, F5GYT4, E7EVS6, B4DW52
Gene-Disease Assocation DYSTONIA, JUVENILE-ONSET
Search EB-eye ENSG00000075624
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-GEOD-7224, E-GEOD-3526, ... (30 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (35 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-3529, E-GEOD-19639, E-GEOD-5823, E-GEOD-20081
SW480
3
E-MEXP-1014, E-MTAB-37, E-GEOD-18005
BT-474
2
E-GEOD-5823, E-GEOD-3529
HCC95
2
E-MTAB-62, E-GEOD-4342
U251
2
E-GEOD-20089, E-MTAB-62
HCC-1428
1
E-GEOD-19639
362 more value(s).


Cell type

studied in E-GEOD-16058, E-MEXP-1121, E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, ... (45 experiments)

Factor Value U/D Experiments
1
2
E-TABM-145, E-TABM-130
fibroblast
2
E-GEOD-3920, E-GEOD-26672
CD326negCD56+ cell
1
E-GEOD-21668
SCC
1
E-GEOD-19188
CD56+ NK cells
1
E-AFMX-5
hematopoietic
1
E-GEOD-9894
95 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-12254, ... (70 experiments)

Factor Value U/D Experiments
glioblastoma
1
4
E-GEOD-6014, E-GEOD-4290, E-MTAB-62, E-MTAB-37, E-MEXP-567 ... (5 experiments)
lung adenocarcinoma
3
E-MTAB-37, E-MEXP-231, E-MTAB-62
multiple myeloma
3
E-MTAB-62, E-GEOD-6691, E-GEOD-2113
chronic myelogenous leukemia
2
E-MTAB-62, E-GEOD-96
gastric carcinoma
2
E-MTAB-37, E-GEOD-2685
Burkitt's lymphoma
2
E-GEOD-1880, E-MTAB-37
239 more value(s).


Compound treatment

studied in E-GEOD-7400, E-TABM-782, E-GEOD-3720, E-GEOD-5824, E-MEXP-1958, ... (27 experiments)

Factor Value U/D Experiments
lipopolysaccharide
2
E-MEXP-1958, E-GEOD-3720
dimethyl sulfoxide
2
E-GEOD-5824, E-GEOD-6932
ethanol
2
E-MEXP-2241, E-GEOD-3113
none
5
6
E-MEXP-1269, E-GEOD-5824, E-GEOD-2803, E-GEOD-412, E-TABM-782, ... (11 experiments)
unknown
1
E-GEOD-7307
control - untreated
1
E-GEOD-7216
32 more value(s).


A rna yield

studied in E-TABM-325

Factor Value U/D Experiments
74.51
1
1
E-TABM-325


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd38
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

Chromosomal aberration
studied in E-TABM-125

Classifier
studied in E-GEOD-3493

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, ... (12 experiments)

Clinical info
studied in E-GEOD-19743, E-MEXP-1251, E-GEOD-21374, E-GEOD-1563, E-GEOD-21589, ... (13 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

Construct
studied in E-GEOD-22366

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-GEOD-1614, E-GEOD-16058, E-GEOD-6236, ... (7 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-GEOD-6431

Genotype
studied in E-GEOD-22056, E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, E-TABM-868, ... (10 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-MEXP-1220, E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-20540, ... (11 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-2466, E-MEXP-2069, E-GEOD-1926, ... (43 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-GEOD-9723, E-GEOD-512

Injury
studied in E-GEOD-19743

Irradiate
studied in E-TABM-321, E-MEXP-2177

Karyotype
studied in E-GEOD-22056

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-MEXP-958

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Performer
studied in E-GEOD-2004, E-LGCL-5

Phenotype
studied in E-GEOD-21750, E-GEOD-6434, E-GEOD-1657, E-GEOD-1460

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-1880, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

pt
studied in E-GEOD-21653

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797, E-TABM-585, E-GEOD-19330, E-GEOD-18791

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1315, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2508, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Tissue
studied in E-GEOD-30573

tissue (organ)
studied in E-GEOD-22601

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, ... (7 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.445 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM